Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Peter O'Donovan is active.

Publication


Featured researches published by Peter O'Donovan.


Prostaglandins Leukotrienes and Essential Fatty Acids | 2010

Lipidomic analysis reveals prostanoid profiles in human term pregnant myometrium

Jh Durn; Kay Marshall; Diane Farrar; Peter O'Donovan; Andy J. Scally; David F. Woodward; Anna Nicolaou

Prostanoids modulate the activity of human pregnant myometrium and their functional role can be appreciated through characterisation of prostanoid receptors and tissue concentration of prostanoids. We have applied a lipidomic approach to elucidate the profile of prostanoids in human non-labouring and labouring myometrium. We have identified a total of nineteen prostanoids including prostacyclin, thromboxanes, prostaglandins and dihydro-prostaglandins. Prostacyclin was the predominant prostanoid in both non-labouring and labouring myometria, with PGD(2) and PGF(2alpha) being the second most abundant. Although the total amount of prostanoids was increased in the labouring tissue, PGE(2) and 13,14-dihydro-15-keto-PGE(2) were the only prostanoids to increase significantly at early and late labour (p< or =0.001). Our data suggest that PGF(2alpha) plays an important role in parturition, whilst the increase in PGE(2) could occur to facilitate cervical dilation and relaxation of the lower myometrium during labour. Although the elevation in TXA(2) was less marked than expected, in terms of translation to function even a relatively small increase in the level of this potent spasmogen may have significant effects.


Obstetrics and Gynecology International | 2012

Radiofrequency Ablation for Treatment of Symptomatic Uterine Fibroids

Siân Jones; Peter O'Donovan; David Toub

The use of thermal energy-based systems to treat uterine fibroids has resulted in a plethora of devices that are less invasive and potentially as effective in reducing symptoms as traditional options such as myomectomy. Most thermal ablation devices involve hyperthermia (heating of tissue), which entails the conversion of an external electromagnetic or ultrasound waves into intracellular mechanical energy, generating heat. What has emerged from two decades of peer-reviewed research is the concept that hyperthermic fibroid ablation, regardless of the thermal energy source, can create large areas of necrosis within fibroids resulting in reductions in fibroid volume, associated symptoms and the need for reintervention. When a greater percentage of a fibroids volume is ablated, symptomatic relief is more pronounced, quality of life increases, and it is more likely that such improvements will be durable. We review radiofrequency ablation (RFA), one modality of hyperthermic fibroid ablation.


British Journal of Obstetrics and Gynaecology | 1988

Is routine antenatal booking vaginal examination necessary for reasons other than cervical cytology if ultrasound examination is planned

Peter O'Donovan; Janesh K. Gupta; John Savage; Jim Thornton; Richard Lilford

Summary. Sixteen ovarian cysts, including one borderline ovarian malignancy, and ten trichomonal vaginal discharges but no cases of cervical incompetence or ectopic pregnancy had been detected at booking vaginal examination in 11 622 consecutive antenatal case records abstracted retrospectively. In an attitude survey of pregnant women 77% believed that vaginal examination was reassuring, 55% found it unpleasant, and 18% thought it could cause miscarriage. This, and a review of the literature, suggests that routine vaginal examination if ultrasound is planned has few advantages beyond the taking of a cervical smear.


Journal of Obstetrics and Gynaecology | 2001

Outcome of outpatient micro-hysteroscopy performed for abnormal bleeding while on hormone replacement therapy

Majella G. Okeahialam; Sian E. Jones; Peter O'Donovan

This retrospective observational study was carried out in a large district general hospital to review the outcome of outpatient micro-hysteroscopy performed on women with abnormal bleeding while on hormone replacement therapy. All women referred to the outpatient hysteroscopy unit with abnormal bleeding while on hormone replacement therapy between November 1994 and August 1998 had hysteroscopy performed using a 1·2 mm semi-rigid hysteroscope with a 2·5 mm sheath. Hysteroscopy was performed on 190 women. Ninety-two women (48·4%) had a normal uterine cavity, 38 (20%) had an atrophic endometrium, 52 (27·4%) were found to have endometrial polyps, seven (3·7%) had suspicious endometrium (histology showed two adenocarcinomas and three hyperplasias) and one patient (0·5%) had a submucous fibroid. Histological evaluation showed 145 (76·32%) specimens were benign, 37 (19·47%) specimens either contained no tissue or insufficient tissue for diagnosis, five (2·63%) showed hyperplasia and three (1·58%) were adenocarcinoma. Two hyperplasias and one focal adenocarcinoma were diagnosed in endometrial polyps. Nearly half of the women who had a hysteroscopy for abnormal bleeding while on hormone replacement therapy had a normal endometrial cavity. Almost one-third had endometrial pathology, of which the majority were endometrial polyps. The incidence of endometrial carcinoma was low. No abnormality was missed on hysteroscopy, but histology was normal in two patients with hysteroscopically suspicious endometrium.This retrospective observational study was carried out in a large district general hospital to review the outcome of outpatient micro-hysteroscopy performed on women with abnormal bleeding while on hormone replacement therapy. All women referred to the outpatient hysteroscopy unit with abnormal bleeding while on hormone replacement therapy between November 1994 and August 1998 had hysteroscopy performed using a 1.2 mm semi-rigid hysteroscope with a 2.5 mm sheath. Hysteroscopy was performed on 190 women. Ninety-two women (48.4%) had a normal uterine cavity, 38 (20%) had an atrophic endometrium, 52 (27.4%) were found to have endometrial polyps, seven (3.7%) had suspicious endometrium (histology showed two adenocarcinomas and three hyperplasias) and one patient (0.5%) had a submucous fibroid. Histological evaluation showed 145 (76.32%) specimens were benign, 37 (19.47%) specimens either contained no tissue or insufficient tissue for diagnosis, five (2.63%) showed hyperplasia and three (1.58%) were adenocarcinoma. Two hyperplasias and one focal adenocarcinoma were diagnosed in endometrial polyps. Nearly half of the women who had a hysteroscopy for abnormal bleeding while on hormone replacement therapy had a normal endometrial cavity. Almost one-third had endometrial pathology, of which the majority were endometrial polyps. The incidence of endometrial carcinoma was low. No abnormality was missed on hysteroscopy, but histology was normal in two patients with hysteroscopically suspicious endometrium.


Reviews in Gynaecological Practice | 2001

Recent advances in electrosurgery—VERSAPOINT® technology

Martin Farrugia; Paul McGurgan; Lindsey McMillan; Peter O'Donovan

Abstract Electrosurgery is the generation and delivery of an alternating current between an active and a return electrode in order to raise the tissue temperature for the purposes of desiccation and cutting. The tissue effect achieved is dependent on a number of factors, which include peak voltage, the frequency of the alternating current, modulation, type of tissue, shape of the electrode and the time energy is applied for. In operative hysteroscopy, the energy source and the distension medium used are closely linked. The use of a cheaper and more versatile electrosurgery generator instead of laser energy has been offset by the risk of serious complications resulting from the use of non-ionic distension media. VERSAPOINT® bipolar technology has combined electrosurgery with a safer distension medium, saline.


Best Practice & Research in Clinical Obstetrics & Gynaecology | 2006

Ambulatory hysteroscopy: evidence-based guide to diagnosis and therapy

Shagaf H. Bakour; Siân Jones; Peter O'Donovan


Journal of Endocrinology | 2008

Loss of prostaglandin F2α, but not thromboxane, responsiveness in pregnant human myometrium during labour

Deborah Fischer; Jonathon A Hutchinson; Diane Farrar; Peter O'Donovan; David F. Woodward; Kay Marshall


Best Practice & Research in Clinical Obstetrics & Gynaecology | 2007

Second-generation endometrial ablation: an overview.

Paul McGurgan; Peter O'Donovan


Gynaecological Endoscopy | 2001

Outpatient microhysteroscopy: why does it fail?

Osama Salha; Majella Okeahialam; Siân Jones; Peter O'Donovan


The Lancet | 2000

Should menstruation be optional for women

Paul Mcgurgan; Peter O'Donovan; S.R.G. Duffy; Rogerson L

Collaboration


Dive into the Peter O'Donovan's collaboration.

Top Co-Authors

Avatar

Siân Jones

Bradford Royal Infirmary

View shared research outputs
Top Co-Authors

Avatar

Diane Farrar

Bradford Royal Infirmary

View shared research outputs
Top Co-Authors

Avatar

Paul Mcgurgan

Bradford Royal Infirmary

View shared research outputs
Top Co-Authors

Avatar

Sian.E. Jones

Bradford Royal Infirmary

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anna Nicolaou

University of Manchester

View shared research outputs
Researchain Logo
Decentralizing Knowledge